Skip to content

Clinical trials

Phase 2 Asthma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 2 Country / region: Canada Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20066
200711
20082
20097
20108
20113
201210
20134
20145
20156
20162
20172
20182
20191
20202
20214
20221
20234
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Terminated13
Active, not recruiting4
Recruiting3
Unknown status3
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline13
AstraZeneca8
Novartis Pharmaceuticals8
MedImmune LLC7
Sanofi7
Boehringer Ingelheim4
Hoffmann-La Roche4
Syntara4
Amgen3
Teva Branded Pharmaceutical Products R&D, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma93
Hypersensitivity5
Lung Diseases5
Respiratory Tract Diseases5
Bronchial Diseases4
Respiratory Hypersensitivity4
Rhinitis4
Cystic Fibrosis3
Hypersensitivity, Immediate2
Immune System Diseases2

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.